AU7034691A - Lipoprotein signal peptide fused to antigenic polypeptides - Google Patents
Lipoprotein signal peptide fused to antigenic polypeptidesInfo
- Publication number
- AU7034691A AU7034691A AU70346/91A AU7034691A AU7034691A AU 7034691 A AU7034691 A AU 7034691A AU 70346/91 A AU70346/91 A AU 70346/91A AU 7034691 A AU7034691 A AU 7034691A AU 7034691 A AU7034691 A AU 7034691A
- Authority
- AU
- Australia
- Prior art keywords
- signal peptide
- antigenic polypeptides
- peptide fused
- lipoprotein signal
- lipoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004895 Lipoproteins Human genes 0.000 title 1
- 108090001030 Lipoproteins Proteins 0.000 title 1
- 108010076504 Protein Sorting Signals Proteins 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45647389A | 1989-12-26 | 1989-12-26 | |
US456473 | 1989-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7034691A true AU7034691A (en) | 1991-07-24 |
Family
ID=23812898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU70346/91A Abandoned AU7034691A (en) | 1989-12-26 | 1990-12-27 | Lipoprotein signal peptide fused to antigenic polypeptides |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0510018A1 (de) |
AU (1) | AU7034691A (de) |
CA (1) | CA2032914A1 (de) |
WO (1) | WO1991009952A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5777095A (en) * | 1988-10-24 | 1998-07-07 | Symbicom Aktiebolag | Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90 |
US6143872A (en) * | 1988-10-24 | 2000-11-07 | Symbicom Aktiebolag | Borrelia burdorferi Osp A and B proteins and immunogenic peptides |
AU681572B2 (en) * | 1991-10-21 | 1997-09-04 | Med Immune, Inc. | Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins |
FR2708622B1 (fr) * | 1993-08-02 | 1997-04-18 | Raymond Hamers | Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides. |
US6335018B1 (en) | 1995-05-01 | 2002-01-01 | Aventis Pasteur Limited | High molecular weight major outer membrane protein of moraxella |
US6440425B1 (en) * | 1995-05-01 | 2002-08-27 | Aventis Pasteur Limited | High molecular weight major outer membrane protein of moraxella |
ZA964896B (en) | 1995-06-07 | 1997-01-08 | Connaught Lab | Expression of lipoproteins |
EP1741718A3 (de) * | 1995-06-07 | 2007-03-28 | Sanofi Pasteur Inc. | Expression von lipoproteinen |
US6251405B1 (en) * | 1995-06-07 | 2001-06-26 | Connaught Laboratories, Inc. | Immunological combination compositions and methods |
CN108135181A (zh) * | 2015-09-04 | 2018-06-08 | 斯克利普斯研究院 | 定新型抗生素及相关组合物的方法 |
US11446398B2 (en) | 2016-04-11 | 2022-09-20 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
WO2020086742A1 (en) | 2018-10-24 | 2020-04-30 | Obsidian Therapeutics, Inc. | Er tunable protein regulation |
EP3935159A1 (de) | 2019-03-08 | 2022-01-12 | Obsidian Therapeutics, Inc. | Menschliche carboanhydrase-2-zusammensetzungen und verfahren zur abstimmbaren regulierung |
US20220267398A1 (en) | 2019-06-12 | 2022-08-25 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
US20220259284A1 (en) | 2019-06-12 | 2022-08-18 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
US20220348937A1 (en) | 2019-09-06 | 2022-11-03 | Obsidian Therapeutics, Inc. | Compositions and methods for dhfr tunable protein regulation |
-
1990
- 1990-12-21 CA CA 2032914 patent/CA2032914A1/en not_active Abandoned
- 1990-12-27 EP EP19910901263 patent/EP0510018A1/de not_active Withdrawn
- 1990-12-27 WO PCT/CA1990/000460 patent/WO1991009952A1/en not_active Application Discontinuation
- 1990-12-27 AU AU70346/91A patent/AU7034691A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0510018A1 (de) | 1992-10-28 |
WO1991009952A1 (en) | 1991-07-11 |
CA2032914A1 (en) | 1991-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU570004B2 (en) | Antigenic modification of peptides | |
IL94243A0 (en) | Fusion polypeptide and its preparation | |
AU7034691A (en) | Lipoprotein signal peptide fused to antigenic polypeptides | |
ZA901737B (en) | Peptides | |
AU3977589A (en) | Novel peptides | |
AU1957288A (en) | Synthetic peptides related to hiv-env proteins | |
AU4927390A (en) | Fusion proteins | |
GB8920357D0 (en) | Peptides | |
GB8817160D0 (en) | Novel proteins | |
AU5407190A (en) | Peptides having novel polar n-terminal groups | |
IL93447A0 (en) | Milled proteins | |
AU2684388A (en) | Peptides acting to influence the mammalian pituitary | |
AU6938987A (en) | Lymphocyte-activating polypeptides | |
GB2248839B (en) | Process for the separation of proteins or polypeptides | |
ZA901695B (en) | Recombinant protein receptor | |
GB8905606D0 (en) | Peptides | |
AU3253689A (en) | A process for the preparation of proteins which start with n-terminal proline | |
GB9025320D0 (en) | N-terminal modification of proteins | |
EP0470520A3 (en) | Process for the preparation of peptides or polypeptides in a cell-free translation system | |
IE881482L (en) | Recombinant htlv-iii proteins | |
AU6087990A (en) | Psycho-pharmacological peptides | |
GB8913991D0 (en) | Recombinant hybrid proteins | |
IE891280L (en) | Recombinant antibodies | |
GB8921172D0 (en) | Proteins | |
GB8820923D0 (en) | Peptide sequence & antibody thereto |